↓ Skip to main content

Oxidative Stress and Neuroprotection

Overview of attention for book
Cover of 'Oxidative Stress and Neuroprotection'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Levodopa in the treatment of Parkinson’s disease
  3. Altmetric Badge
    Chapter 2 Changing dopamine agonist treatment in Parkinson’s disease: experiences with switching to pramipexole
  4. Altmetric Badge
    Chapter 3 The DONPAD-study — Treatment of dementia in patients with Parkinson’s disease with donepezil
  5. Altmetric Badge
    Chapter 4 PD-related psychosis: pathophysiology with therapeutical strategies
  6. Altmetric Badge
    Chapter 5 Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.
  7. Altmetric Badge
    Chapter 6 Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines — implications for the CNS
  8. Altmetric Badge
    Chapter 7 Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
  9. Altmetric Badge
    Chapter 8 Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection
  10. Altmetric Badge
    Chapter 9 The relationship of early studies of monoamine oxidase to present concepts
  11. Altmetric Badge
    Chapter 10 Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson’s disease induced by the Japanese encephalitis virus
  12. Altmetric Badge
    Chapter 11 Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl
  13. Altmetric Badge
    Chapter 12 Inhibition of amine oxidases by the histamine-1 receptor antagonist hydroxyzine
  14. Altmetric Badge
    Chapter 13 Neuroprotection for Parkinson’s disease
  15. Altmetric Badge
    Chapter 14 Marker for a preclinical diagnosis of Parkinson’s disease as a basis for neuroprotection
  16. Altmetric Badge
    Chapter 15 Assessing neuroprotection in Parkinson’s disease: from the animal models to molecular neuroimaging in vivo
  17. Altmetric Badge
    Chapter 16 Deprenyl: from chemical synthesis to neuroprotection
  18. Altmetric Badge
    Chapter 17 The use of rasagiline in Parkinson’s disease
  19. Altmetric Badge
    Chapter 18 Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases
  20. Altmetric Badge
    Chapter 19 Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain
  21. Altmetric Badge
    Chapter 20 Long lasting effects of infancy iron deficiency — Preliminary results
  22. Altmetric Badge
    Chapter 21 Altered regulation of iron transport and storage in Parkinson’s disease
  23. Altmetric Badge
    Chapter 22 Iron dyshomeostasis in Parkinson’s disease
  24. Altmetric Badge
    Chapter 23 Cerebral oligemia and iron influence in cerebral structures — element of Morbus Parkinson Models?
  25. Altmetric Badge
    Chapter 24 Impact of selenium, iron, copper and zinc in on/off Parkinson’s patients on L-dopa therapy
  26. Altmetric Badge
    Chapter 25 Metal specificity of an iron-responsive element in Alzheimer’s APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator
  27. Altmetric Badge
    Chapter 26 Green tea catechins as brain-permeable, non toxic iron chelators to “iron out iron” from the brain
Attention for Chapter 7: Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
Altmetric Badge

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
Chapter number 7
Book title
Oxidative Stress and Neuroprotection
Published in
Journal of neural transmission Supplementum, December 2005
DOI 10.1007/978-3-211-33328-0_7
Pubmed ID
Book ISBNs
978-3-21-133327-3, 978-3-21-133328-0
Authors

Nagatsu T, Sawada M, Nagatsu, T., Sawada, M., T. Nagatsu, M. Sawada

Abstract

Monoamine oxidases A and B (MAO A and MAO B) are the major enzymes that catalyze the oxidative deamination of monoamine neurotaransmitters such as dopamine (DA), noradrenaline, and serotonin in the central and peripheral nervous systems. MAO B is mainly localized in glial cells. MAO B also oxidizes the xenobiotic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to a parkinsonism-producing neurotoxin, 1-methyl-4-phenyl-pyridinium (MPP+). MAO B may be closely related to the pathogenesis of Parkinson's disease (PD), in which neuromelanin-containing DA neurons in the substantia nigra projecting to the striatum in the brain selectively degenerate. MAO B degrades the neurotransmitter DA that is deficient in the nigro-striatal region in PD, and forms H2O2 and toxic aldehyde metabolites of DA. H2O2 produces highly toxic reactive oxygen species (ROS) by Fenton reaction that is catalyzed by iron and neuromelanin. MAO B inhibitors such as L-(-)-deprenyl (selegiline) and rasagiline are effective for the treatment of PD. Concerning the mechanism of the clinical efficacy of MAO B inhibitors in PD, the inhibition of DA degradation (a symptomatic effect) and also the prevention of the formation of neurotoxic DA metabolites, i.e., ROS and dopamine derived aldehydes have been speculated. As another mechanism of clinical efficacy, MAO B inhibitors such as selegiline are speculated to have neuroprotective effects to prevent progress of PD. The possible mechanism of neuroprotection of MAO B inhibitors may be related not only to MAO B inhibition but also to induction and activation of multiple factors for anti-oxidative stress and anti-apoptosis: i.e., catalase, superoxide dismutase 1 and 2, thioredoxin, Bcl-2, the cellular poly(ADP-ribosyl)ation, and binding to glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Furthermore, it should be noted that selegiline increases production of neurotrophins such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrphic factor (GDNF), possibly from glial cells, to protect neurons from inflammatory process.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
China 1 <1%
Australia 1 <1%
Unknown 107 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 17%
Student > Master 17 15%
Student > Bachelor 14 13%
Researcher 11 10%
Student > Doctoral Student 5 5%
Other 14 13%
Unknown 30 27%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 20%
Biochemistry, Genetics and Molecular Biology 14 13%
Medicine and Dentistry 11 10%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Neuroscience 8 7%
Other 11 10%
Unknown 35 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#7,454,298
of 22,789,076 outputs
Outputs from Journal of neural transmission Supplementum
#21
of 99 outputs
Outputs of similar age
#39,885
of 153,958 outputs
Outputs of similar age from Journal of neural transmission Supplementum
#3
of 11 outputs
Altmetric has tracked 22,789,076 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 99 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 153,958 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.